T h e r a p e u t i c I n d e x 214 Composition Each Reosto tablet contains: Pdrs. Guggulu (Commiphora wightii).......................... 235 mg Bala (Sida cordifolia)............................................... 45 mg Godanti bhasma...................................................... 120 mg Arjuna (Terminalia arjuna).................................... 45 mg Rasna (Pluchea lanceolata).....................................50 mg Ashvagandha (Withania somnifera).................. 45 mg Kukkutandatvak bhasma...................................... 35 mg Processed in Vamsa (Bambusa arundinacea), Kumari (Aloe vera), and Dhanyaka (Coriandrum sativum). Clinical Pharmacology Reosto promotes remineralization of bones, exerts phytoestrogenic, calcium-supplementation, anti-inflammatory, antioxidant, and adaptogenic actions, and controls associated risk factors. Reosto restores the increased levels of alkaline phosphatase (indicating beneficial effect on bone formation), and decreases the urinary excretion of pyridinoline, deoxypyridinoline, and hydroxyproline (indicating inhibition of bone resorption). Thus, Reosto inhibits bone resorption and favorably influences bone formation. Indications • Osteoporosis: – Senile osteoporosis – Postmenopausal osteoporosis • Immobilization following fractures Dosage 2 tablets twice daily, followed by 1 tablet twice daily as maintenance dose. Adverse Effects No adverse effects have been reported. Reosto® (tablet) Restores bone health Reosto, an Ayurvedic proprietary formulation, is recommended for the treatment of senile and postmenopausal osteoporosis, and in immobilized patients following bone fracture. The elemental calcium in Reosto helps increase bone mineral density (BMD) and serum calcium levels. Reosto inhibits bone resorption, favorably influences bone formation and increases bone mass, and prevents the risk of osteoporotic fractures.
RkJQdWJsaXNoZXIy MjMwNjM2Nw==